JP2008543729A5 - - Google Patents

Download PDF

Info

Publication number
JP2008543729A5
JP2008543729A5 JP2007558257A JP2007558257A JP2008543729A5 JP 2008543729 A5 JP2008543729 A5 JP 2008543729A5 JP 2007558257 A JP2007558257 A JP 2007558257A JP 2007558257 A JP2007558257 A JP 2007558257A JP 2008543729 A5 JP2008543729 A5 JP 2008543729A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007558257A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008543729A (ja
JP5110697B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2007558257A priority Critical patent/JP5110697B2/ja
Priority claimed from JP2007558257A external-priority patent/JP5110697B2/ja
Publication of JP2008543729A publication Critical patent/JP2008543729A/ja
Publication of JP2008543729A5 publication Critical patent/JP2008543729A5/ja
Application granted granted Critical
Publication of JP5110697B2 publication Critical patent/JP5110697B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2007558257A 2005-06-27 2006-06-26 固形製剤 Active JP5110697B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007558257A JP5110697B2 (ja) 2005-06-27 2006-06-26 固形製剤

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2005187214 2005-06-27
JP2005187214 2005-06-27
JP2007558257A JP5110697B2 (ja) 2005-06-27 2006-06-26 固形製剤
PCT/JP2006/313176 WO2007001067A2 (en) 2005-06-27 2006-06-26 Solid dosage form comprising an angiotensin ii receptor antagonist and a calcium channel blocker

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012177601A Division JP5456857B2 (ja) 2005-06-27 2012-08-09 固形製剤

Publications (3)

Publication Number Publication Date
JP2008543729A JP2008543729A (ja) 2008-12-04
JP2008543729A5 true JP2008543729A5 (uk) 2009-08-06
JP5110697B2 JP5110697B2 (ja) 2012-12-26

Family

ID=37460221

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007558257A Active JP5110697B2 (ja) 2005-06-27 2006-06-26 固形製剤
JP2012177601A Active JP5456857B2 (ja) 2005-06-27 2012-08-09 固形製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012177601A Active JP5456857B2 (ja) 2005-06-27 2012-08-09 固形製剤

Country Status (3)

Country Link
JP (2) JP5110697B2 (uk)
TW (1) TWI388345B (uk)
WO (1) WO2007001067A2 (uk)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6469753B1 (en) 1996-05-03 2002-10-22 Starsight Telecast, Inc. Information system
GT200600371A (es) * 2005-08-17 2007-03-21 Formas de dosis sólidas de valsartan y amlodipina y método para hacer las mismas
US9113107B2 (en) 2005-11-08 2015-08-18 Rovi Guides, Inc. Interactive advertising and program promotion in an interactive television system
US20100237530A1 (en) * 2006-06-27 2010-09-23 Daiichi Sankyo Company, Limited Compressed preparation
US20080175872A1 (en) * 2006-09-28 2008-07-24 Osmotica Corp. Controlled Release Dosage Form Containing Lercanidipine and a Performance-enhancing Acid
US8832742B2 (en) 2006-10-06 2014-09-09 United Video Properties, Inc. Systems and methods for acquiring, categorizing and delivering media in interactive media guidance applications
KR101247583B1 (ko) * 2006-12-08 2013-03-26 한미사이언스 주식회사 암로디핀 또는 이의 약제학적 허용가능한 염, 및 로자탄또는 이의 약제학적 허용가능한 염을 함유하는 약제학적조성물
TWI488658B (zh) * 2006-12-26 2015-06-21 Daiichi Sankyo Co Ltd 溶出性之改善方法
TWI414310B (zh) * 2006-12-26 2013-11-11 Daiichi Sankyo Co Ltd 溶出性改善之醫藥品組成物
TWI402083B (zh) * 2006-12-26 2013-07-21 Daiichi Sankyo Co Ltd 固形製劑及其安定化方法
JP2011510049A (ja) * 2008-01-25 2011-03-31 デュオ−ジェーウー 包材により結合する経口医薬の組み合わせ
JP5554699B2 (ja) 2008-03-13 2014-07-23 第一三共株式会社 オルメサルタンメドキソミルを含む製剤の溶出性の改善
TW201014850A (en) * 2008-09-25 2010-04-16 Takeda Pharmaceutical Solid pharmaceutical composition
UA102721C2 (uk) * 2009-01-23 2013-08-12 Ханми Сайенс Ко., Лтд. Тверда фармацевтична композиція, яка містить амлодипін і лозартан, і спосіб її отримання
MX2011014005A (es) * 2009-06-30 2012-04-30 Sanofi Sa Composiciones de sodis fija farmaceuticas solidas que comprenden irbesartan y amlodipina, su preparacion y su uso terapeutica.
JP5886530B2 (ja) * 2010-02-26 2016-03-16 第一三共株式会社 錠剤
JP5421945B2 (ja) * 2010-03-10 2014-02-19 大日本住友製薬株式会社 イルベサルタンとアムロジピンまたはその塩を含有する医薬組成物
JP5824222B2 (ja) * 2010-03-31 2015-11-25 第一三共株式会社 固形製剤の製造方法
EA025946B1 (ru) * 2010-10-27 2017-02-28 Крка, Товарна Здравил, Д. Д., Ново Место Многослойная фармацевтическая композиция, содержащая телмисартан и амлодипин
UY33772A (es) 2010-12-09 2012-07-31 Lg Life Sciences Ltd Composición farmacéutica que comprende clorhidrato de lercanidipina y valsartán como componentes activos y a un método para la preparacion de la misma.
JP6041591B2 (ja) * 2011-09-13 2016-12-14 大日本住友製薬株式会社 イルベサルタンとアムロジピンまたはその塩を含有する安定化された医薬組成物
WO2014058046A1 (ja) * 2012-10-12 2014-04-17 味の素株式会社 カルシウム拮抗薬/アンジオテンシンii受容体拮抗薬含有医薬製剤
MX2013001277A (es) * 2013-01-31 2014-07-30 Miguel Ángel García Pérez Composicion farmaceutica con un antagonista de los receptores de la angiotensina ii y un bloqueador de los canales de calcio para el tratamiento de la hipertension arterial.
CN103127110A (zh) * 2013-03-18 2013-06-05 吉林省博大伟业制药有限公司 含有血管紧张素ⅱ受体拮抗剂和钙通道阻断剂的复方制剂
CN103271908B (zh) * 2013-05-23 2019-02-12 浙江华海药业股份有限公司 含有替米沙坦和苯磺酸氨氯地平的口服片剂及其制备方法
EP3025711B1 (en) * 2013-07-23 2020-11-18 Daiichi Sankyo Company, Limited Medicine for preventing or treating hypertension
CN103908539B (zh) * 2014-05-03 2017-02-01 李全浩 一种治疗高血压的中药组合物及其制备方法及应用
CN104000821B (zh) * 2014-06-02 2020-06-19 浙江华海药业股份有限公司 含有替米沙坦和苯磺酸氨氯地平的口服双层片剂及其制备方法
WO2016114725A1 (en) * 2015-01-12 2016-07-21 İlko İtaç Sanayi Ve Ticaret Anonim Şirketi A stable bilayer pharmaceutical tablet compositions comprising fixed dose of irbesartan and amlodipine
KR20180123021A (ko) * 2016-03-24 2018-11-14 다이이찌 산쿄 가부시키가이샤 신질환의 치료를 위한 의약
CN109432034A (zh) * 2018-12-28 2019-03-08 乐普制药科技有限公司 一种缬沙坦氨氯地平三层片剂及其制备方法
CN110237073B (zh) * 2019-07-10 2022-12-02 安庆回音必制药股份有限公司 一种奥美沙坦酯氨氯地平片及其制备方法
CN114712319B (zh) * 2022-03-25 2024-01-09 北京诺康达医药科技股份有限公司 一种非洛地平盐酸普萘洛尔复方制剂及其制备方法
CN115227662B (zh) * 2022-06-24 2023-11-24 辰欣药业股份有限公司 一种缬沙坦氨氯地平片剂及其制备方法
CN115944600B (zh) * 2022-12-01 2024-05-28 山东齐都药业有限公司 含有替米沙坦和苯磺酸氨氯地平的口服片剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0859470A (ja) * 1994-08-29 1996-03-05 Sankyo Co Ltd シクロペンタ[d]ピリミジン誘導体の溶出性改善製剤
US6395728B2 (en) * 1999-07-08 2002-05-28 Novartis Ag Method of treatment and pharmaceutical composition
CN100571695C (zh) * 2002-01-16 2009-12-23 贝林格尔英格海姆法玛两合公司 含有替米沙坦和利尿剂的双层药片及其制备方法
JP3751287B2 (ja) * 2002-03-27 2006-03-01 バイエル薬品株式会社 小型化されたニフェジピン有核錠剤
AU2003227472A1 (en) * 2002-03-27 2003-10-08 Bayer Aktiengesellschaft Downsized core tablet containing nifedipine
EG24716A (en) * 2002-05-17 2010-06-07 Novartis Ag Combination of organic compounds
US20040198789A1 (en) * 2003-02-28 2004-10-07 Recordati Ireland Limited Lercanidipine/ARB/diuretic therapeutic combinations
JP2004300102A (ja) * 2003-03-31 2004-10-28 Kissei Pharmaceut Co Ltd 縮合複素環誘導体、それを含有する医薬組成物およびその医薬用途
WO2005070462A2 (en) * 2004-01-12 2005-08-04 Sepracor, Inc. Compositions comprising (s)-amlodipine and an angiotensin receptor blocker and methods of their use
PT1814527E (pt) * 2004-11-05 2014-01-16 Boehringer Ingelheim Int Comprimido de bicamada compreendendo telmisartan e amlodipina

Similar Documents

Publication Publication Date Title
JP2008543290A5 (uk)
JP2008543728A5 (uk)
JP2009511485A5 (uk)
JP2008543729A5 (uk)
JP2009507826A5 (uk)
JP2008533230A5 (uk)
JP2009543688A5 (uk)
JP2009538387A5 (uk)
JP2009506999A5 (uk)
JP2009525726A5 (uk)
JP2008543830A5 (uk)
JP2009503140A5 (uk)
JP2009542573A5 (uk)
JP2007321035A5 (uk)
JP2006257115A5 (uk)
JP2007231207A5 (uk)
JP2008538930A5 (uk)
JP2009520703A5 (uk)
JP2006063441A5 (uk)
JP2007246653A5 (uk)
JP2007190226A5 (uk)
JP2006273834A5 (uk)
JP2007254440A5 (uk)
JP2009512653A5 (uk)
JP2010530463A5 (uk)